Background: In cardiovascular engineering, the recent introduction of soft robotic technologies sheds new light on the future of implantable cardiac devices, enabling the replication of complex bioinspired architectures and motions. To support human heart function, assistive devices and total artificial hearts have been developed. However, the system's functionality, hemocompatibility, and overall implantability are still open challenges.
Methods: Here, the design of a soft robotic artificial cardiac wall is presented: the action of a bioinspired myocardium of pneumatic McKibben actuators in a double helix is coupled with an engineered passive and deformable endocardial layer made of silicone. The correlation between the helix angle of the actuators and the ejection fraction of the artificial cardiac wall was preliminarily studied with a simplified analytical model. A FEM model was introduced to represent the complex deformation of the endocardial layer during the actuation of the cardiac wall.
Results: Experimental tests report an ejection fraction of 68%, i.e., 77.2 ± 0.4 mL against 90 mmHg, satisfying the minimum physiological requirements and, therefore, proving the concept's functionality.
Conclusions: The conceived device paves the way for a new generation of innovative approaches where engineered bioinspiration might be the key to future artificial cardiac pumps that could support or even substitute the human failing heart.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/aor.14978 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association.
Europace
March 2025
Clinical Cardiac Academic Group, Genetic and Cardiovascular Sciences Institute, City-St George's University of London, London, UK.
Atrial fibrillation (AF) is one of the most common cardiac diseases and a complicating comorbidity for multiple associated diseases. Many clinical decisions regarding AF are currently based on the binary recognition of AF being present or absent with the categorical appraisal of AF as continued or intermittent. Assessment of AF in clinical trials is largely limited to the time to (first) detection of an AF episode.
View Article and Find Full Text PDFDesign of a Soft Robotic Artificial Cardiac Wall.
Artif Organs
March 2025
The BioRobotics Insitute and Department of Excellence of Robotics & AI, Scuola Superiore Sant'Anna, Pontedera, Italy.
Background: In cardiovascular engineering, the recent introduction of soft robotic technologies sheds new light on the future of implantable cardiac devices, enabling the replication of complex bioinspired architectures and motions. To support human heart function, assistive devices and total artificial hearts have been developed. However, the system's functionality, hemocompatibility, and overall implantability are still open challenges.
View Article and Find Full Text PDFTransfer learning-based hybrid VGG16-machine learning approach for heart disease detection with explainable artificial intelligence.
Front Artif Intell
February 2025
Department of Surgery, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.
Heart disease is a leading cause of mortality worldwide, making accurate early detection essential for effective treatment and management. This study introduces a novel hybrid machine-learning approach that combines transfer learning using the VGG16 convolutional neural network (CNN) with various machine-learning classifiers for heart disease detection. A conditional tabular generative adversarial network (CTGAN) was employed to generate synthetic data samples from actual datasets; these were evaluated using statistical metrics, correlation analysis, and domain expert assessments to ensure the quality of the synthetic datasets.
View Article and Find Full Text PDFLeveraging near-real-time patient and population data to incorporate fluctuating risk of severe COVID-19: development and prospective validation of a personalised risk prediction tool.
EClinicalMedicine
March 2025
VA Boston Cooperative Studies Program, Boston, MA, USA.
Background: Novel strategies that account for population-level changes in dominant variants, immunity, testing practices and changes in individual risk profiles are needed to identify patients who remain at high risk of severe COVID-19. The aim of this study was to develop and prospectively validate a tool to predict absolute risk of severe COVID-19 incorporating dynamic parameters at the patient and population levels that could be used to inform clinical care.
Methods: A retrospective cohort of vaccinated US Veterans with SARS-CoV-2 from July 1, 2021, through August 25, 2023 was created.
Acquired ventricular septal defect secondary to aortic valve endocarditis.
J Cardiothorac Surg
March 2025
University of North Dakota School of Medicine and Health Sciences, 1301 N Columbia Rd Stop 9037, Grand Forks, ND, 58202-9037, USA.
Infective endocarditis remains a deadly disease with a significant mortality rate. While ventricular septal defects (VSDs) have been linked to an increased risk of infective endocarditis, cases of acquired VSDs resulting from infective endocarditis are not well-documented in the literature. Our report highlights a rare case of acquired VSD that resulted directly from aortic valve endocarditis, treated with successful repair and placement of permanent pacemaker.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!